Recent publications

• The Benefits and Pitfalls of Repurposing Drugs*

• Can Health Technology Assessment be Used to Demonstrate Significant Benefit for an Orphan Medicinal Product in the EU

• Is Orphan Drug Status the Answer to Everyone’s Prayers?*

• Cost of Degenerative Cervical Myelopathy to UK society

*In association with Volt Pharma Associates